Scientists receive the Brain Prize for groundbreaking contributions to novel migraine therapies
What:
The Brain Prize has been awarded to Michael A. Moskowitz, M.D., a professor of neurology at Harvard Medical School at the Massachusetts General Hospital, Charlestown, who also is supported by an NIH grant.
The Brain Prize is the world s most prestigious award for brain research and is awarded by the Lundbeck Foundation, Denmark. Dr. Moskowitz will receive the prize along with three other scientists for their pathbreaking contributions that led to novel migraine therapies.
The Lundbeck Foundation said, Moskowitz showed in experimental models that a migraine attack is triggered when trigeminal nerve fibers release neuropeptides that lead to dilated (opened up) blood vessels of the meninges, inflammation, and pain.. He was the first to propose that blocking the action of released neuropeptides could be a new approach to treating migraine.
Lasting Brain Health Risks from COVID-19 Under Study aarp.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from aarp.org Daily Mail and Mail on Sunday newspapers.
E-Mail
IMAGE: Structural model showing the tea flavonoid epicatechin gallate (blue/red) binding to the base of the voltage sensor (green) of KCNQ5, a type of potassium channel found in human blood vessels.. view more
Credit: Geoff Abbott, UCI School of Medicine
Irvine, CA - March 8, 2021 - A new study from the University of California, Irvine shows that compounds in both green and black tea relax blood vessels by activating ion channel proteins in the blood vessel wall. The discovery helps explain the antihypertensive properties of tea and could lead to the design of new blood pressure-lowering medications.
Published in
A rare, painful malady - Writer s Bloc castanet.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from castanet.net Daily Mail and Mail on Sunday newspapers.
While I do not endorse products with which I am not trained and experienced, when I read of something that interests me, I pass it on to you.
In this case, the U.S. Food and Drug Administration has cleared a new over-the-counter device designed to protect children aged 13 years and older from sports-related traumatic brain injury (TBI).
Q30 Sports Science, LLC was granted marketing authorization of the noninvasive device, called Q-Collar. It is a C-shaped collar that applies compressive force to the neck and increases blood volume to help reduce movement of the brain within the cranial space, which may occur because of hits to the head. The device may reduce the occurrence of specific changes in the brain that are associated with brain injury.